RiverGlades Family Offices’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,965
Closed -$219K 78
2023
Q2
$219K Buy
+5,965
New +$219K 0.2% 71
2023
Q1
Sell
-4,750
Closed -$243K 80
2022
Q4
$243K Buy
+4,750
New +$243K 0.22% 68
2022
Q2
$249K Sell
4,750
-2,000
-30% -$105K 0.23% 64
2022
Q1
$349K Sell
6,750
-1,500
-18% -$77.6K 0.26% 62
2021
Q4
$487K Hold
8,250
0.35% 45
2021
Q3
$355K Hold
8,250
0.28% 53
2021
Q2
$323K Hold
8,250
0.25% 61
2021
Q1
$299K Hold
8,250
0.24% 62
2020
Q4
$304K Sell
8,250
-446
-5% -$16.4K 0.26% 58
2020
Q3
$303K Hold
8,696
0.29% 50
2020
Q2
$270K Hold
8,696
0.28% 53
2020
Q1
$269K Buy
+8,696
New +$269K 0.29% 51
2018
Q4
Sell
-6,651
Closed -$278K 70
2018
Q3
$278K Sell
6,651
-1,792
-21% -$74.9K 0.24% 59
2018
Q2
$291K Sell
8,443
-4,058
-32% -$140K 0.25% 56
2018
Q1
$421K Buy
12,501
+5,313
+74% +$179K 0.34% 48
2017
Q4
$247K Buy
+7,188
New +$247K 0.2% 64